First Time Loading...

Dawnrays Pharmaceutical (Holdings) Ltd
HKEX:2348

Watchlist Manager
Dawnrays Pharmaceutical (Holdings) Ltd Logo
Dawnrays Pharmaceutical (Holdings) Ltd
HKEX:2348
Watchlist
Price: 1.23 HKD Market Closed
Updated: May 15, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Dawnrays Pharmaceutical (Holdings) Ltd

Wall Street analysts forecast Dawnrays Pharmaceutical (Holdings) Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dawnrays Pharmaceutical (Holdings) Ltd is 2.75 HKD .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
2.75 HKD
124% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
2.75 HKD
124% Upside
Highest
Price Target
Not Available
Dawnrays Pharmaceutical (Holdings) Ltd Competitors:
Price Targets
SUNPHARMA
Sun Pharmaceutical Industries Ltd
1% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
1% Upside
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
25% Upside
003000
Bukwang Pharm Co Ltd
337% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
1% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
1% Upside
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
25% Upside
003000
Bukwang Pharm Co Ltd
337% Upside
530477
Vikram Thermo (India) Ltd
68% Downside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
40% Upside
000623
Jilin Aodong Pharmaceutical Group Co Ltd
152% Upside
300723
Yipinhong Pharmaceutical Co Ltd
48% Upside

Revenue
Forecast

Revenue Estimate
Dawnrays Pharmaceutical (Holdings) Ltd

For the last 8 years the compound annual growth rate for Dawnrays Pharmaceutical (Holdings) Ltd's revenue is 2%. The projected CAGR for the next 6 years is -2%.

2%
Past Growth
-2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dawnrays Pharmaceutical (Holdings) Ltd

For the last 8 years the compound annual growth rate for Dawnrays Pharmaceutical (Holdings) Ltd's operating income is 2%. The projected CAGR for the next 6 years is 0%.

2%
Past Growth
0%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dawnrays Pharmaceutical (Holdings) Ltd

For the last 8 years the compound annual growth rate for Dawnrays Pharmaceutical (Holdings) Ltd's net income is 1%. The projected CAGR for the next 6 years is -2%.

1%
Past Growth
-2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dawnrays Pharmaceutical (Holdings) Ltd's stock price target?
Price Target
2.75 HKD

According to Wall Street analysts, the average 1-year price target for Dawnrays Pharmaceutical (Holdings) Ltd is 2.75 HKD .

What is Dawnrays Pharmaceutical (Holdings) Ltd's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Dawnrays Pharmaceutical (Holdings) Ltd's revenue is 2%. The projected CAGR for the next 6 years is -2%.

What is Dawnrays Pharmaceutical (Holdings) Ltd's Operating Income forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Dawnrays Pharmaceutical (Holdings) Ltd's operating income is 2%. The projected CAGR for the next 6 years is 0%.

What is Dawnrays Pharmaceutical (Holdings) Ltd's Net Income forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Dawnrays Pharmaceutical (Holdings) Ltd's net income is 1%. The projected CAGR for the next 6 years is -2%.

ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.